News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genentech (RHHBY) Braces for Competition From Amgen (AMGN)-Allergan (AGN) for Best-Selling Drug Avastin



11/17/2016 6:22:06 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
One of Genentech Inc.'s best-selling drugs — and the No. 2 cancer drug worldwide — could get some serious competition, signaling a torrent of cheaper-priced biosimilars.

Amgen Inc., which has research-and-development operations in South San Francisco, and Allergan PLC are asking the Food and Drug Administration to approve a biosimilar version of South San Francisco-based Genentech's tumor-choking Avastin, which is used in a range of cancers, including breast, lung and brain.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES